{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:22:28Z","timestamp":1793110948136,"version":"4.5.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immunoglobulin A (IgA) is the most abundant isotype of antibodies, provides a first line of defense at mucosal surfaces against pathogens, and thereby contributes to mucosal homeostasis. IgA is generally considered as a non-inflammatory antibody because of its main function, neutralizing pathogenic virus or bacteria. Meanwhile, IgA can induce IgA-mediated diseases, such as IgA nephropathy (IgAN) and IgA vasculitis. IgAN is characterized by the deposition of IgA and complement C3, often with IgG and\/or IgM, in the glomerular mesangial region, followed by mesangial cell proliferation and excessive synthesis of extracellular matrix in glomeruli. Almost half a century has passed since the first report of patients with IgAN; it remains debatable about the mechanism how IgA antibodies selectively bind to mesangial region\u2014a hallmark of IgAN\u2014and cause glomerular injuries in IgAN. Previous lectin- and mass-spectrometry-based analysis have revealed that IgAN patients showed elevated serum level of undergalactosylated IgA1 in O-linked glycans of its hinge region, called galactose-deficient IgA1 (Gd-IgA1). Thereafter, numerous studies have confirmed that the glomerular IgA from IgAN patients are enriched with Gd-IgA1; thus, the first hit of the current pathogenesis of IgAN has been considered to increase circulating levels of Gd-IgA1. Recent studies, however, demonstrated that this aberrant glycosylation alone is not sufficient to disease onset and progression, suggesting that several additional factors are required for the selective deposition of IgA in the mesangial region and induce nephritis. Herein, we discuss the current understanding of the characteristics of pathogenic IgA and its mechanism of inducing inflammation in IgAN.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1165394","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T04:52:32Z","timestamp":1681188752000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy"],"prefix":"10.3389","volume":"14","author":[{"given":"Yoshihito","family":"Nihei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.670290","article-title":"The wanderings of gut-derived IgA plasma cells: Impact on systemic immune responses","volume":"12","author":"Keppler","year":"2021","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.09.005","article-title":"IgA as therapeutic antibody","volume":"68","author":"Leusen","year":"2015","journal-title":"Mol Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2976-8","article-title":"The inflammatory function of human IgA","volume":"76","author":"Hansen","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.3390\/ijms20246199","article-title":"The role of IgA in the pathogenesis of IgA nephropathy","volume":"20","author":"Per\u0161e","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00185","article-title":"Multi-faceted functions of secretory IgA at mucosal surfaces","volume":"4","author":"Corth\u00e9sy","year":"2013","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00553","article-title":"IgA and fc\u03b1ri: Pathological roles and therapeutic opportunities","volume":"10","author":"Breedveld","year":"2019","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00874-9","article-title":"IgA vasculitis","volume":"43","author":"Pillebout","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: A systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"B11","article-title":"IgA glomerular deposits in renal disease","volume":"1","author":"Berger","year":"1969","journal-title":"Transplant Proc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.181","article-title":"Charge and size of mesangial IgA in IgA nephropathy","volume":"28","author":"Monteiro","year":"1985","journal-title":"Kidney Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.060003969.x","article-title":"Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients","volume":"60","author":"Allen","year":"2001","journal-title":"Kidney Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590031077.x","article-title":"Mass spectrometry proves under-O-Glycosylation of glomerular IgA1 in iga nephropathy","volume":"59","author":"Hiki","year":"2001","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2018.05.016","article-title":"Aberrant glycosylation of the IgA1 molecule in IgA nephropathy","volume":"38","author":"Novak","year":"2018","journal-title":"Semin Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/jci33189","article-title":"IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1","volume":"118","author":"Suzuki","year":"2008","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv221","article-title":"Novel lectin-independent approach to detect galactose-deficient IgA1 in iga nephropathy","volume":"30","author":"Yasutake","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.10.019","article-title":"IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis","volume":"93","author":"Suzuki","year":"2018","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2020081208","article-title":"O- and n-glycosylation of serum immunoglobulin a is associated with IgA nephropathy and glomerular function","volume":"32","author":"Dotz","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20112005","article-title":"Transglutaminase is essential for IgA nephropathy development acting through IgA receptors","volume":"209","author":"Berthelot","year":"2012","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108525","article-title":"Single-cell transcriptomics reveal immune mechanisms of the onset and progression of IgA nephropathy","volume":"33","author":"Zheng","year":"2020","journal-title":"Cell Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00871-y","article-title":"The mucosal immune system and IgA nephropathy","volume":"43","author":"Gesualdo","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3390\/biomedicines10123027","article-title":"Mucosal immune system dysregulation in the pathogenesis of IgA nephropathy","volume":"10","author":"Kano","year":"2022","journal-title":"Biomedicines"},{"key":"B26","article-title":"Detection of polymeric IgA in glomeruli from patients with iga nephropathy","volume":"49","author":"Tomino","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041811-142014","article-title":"Pathogenesis of immunoglobulin a nephropathy: Recent insight from genetic studies","volume":"64","author":"Kiryluk","year":"2013","journal-title":"Annu Rev Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4772","article-title":"Association between tonsillectomy and outcomes in patients with immunoglobulin a nephropathy","volume":"2","author":"Hirano","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000441852","article-title":"Tonsillectomy in a European cohort of 1,147 patients with IgA nephropathy","volume":"132","author":"Feehally","year":"2016","journal-title":"Nephron"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.08.009","article-title":"Why target the gut to treat IgA nephropathy","volume":"5","author":"Barratt","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.06025.x","article-title":"Celiac disease and hla dq in patients with IgA nephropathy","volume":"97","author":"Collin","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.dld.2017.09.131","article-title":"Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies","volume":"50","author":"Nurmi","year":"2018","journal-title":"Dig Liver Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfz004","article-title":"Inflammatory bowel disease in patients undergoing renal biopsies","volume":"12","author":"Pohjonen","year":"2019","journal-title":"Clin Kidney J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.kint.2022.09.017","article-title":"Results from part a of the multi-center, double-blind, randomized, placebo-controlled nefigard trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin a nephropathy","volume":"103","author":"Barratt","year":"2023","journal-title":"Kidney Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099006","article-title":"Microbiota and metabolome associated with immunoglobulin a nephropathy (Igan)","volume":"9","author":"De Angelis","year":"2014","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"ME21006","DOI":"10.1264\/jsme2.ME21006","article-title":"Dysbiosis in the salivary microbiome associated with IgA nephropathy-a Japanese cohort study","volume":"36","author":"Khasnobish","year":"2021","journal-title":"Microbes Environ"},{"key":"B37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2249.2009.04045.x","article-title":"Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin a nephropathy","volume":"159","author":"Coppo","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e136965","DOI":"10.1172\/jci.insight.136965","article-title":"TLR7 in b cells promotes renal inflammation and gd-IgA1 synthesis in IgA nephropathy","volume":"5","author":"Zheng","year":"2020","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2007121311","article-title":"Toll-like receptor 9 affects severity of IgA nephropathy","volume":"19","author":"Suzuki","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.08.022","article-title":"TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-Mediated pathways in IgA nephropathy","volume":"97","author":"Makita","year":"2020","journal-title":"Kidney Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.6s.2.x","article-title":"Incidence of latent mesangial IgA deposition in renal allograft donors in Japan","volume":"63","author":"Suzuki","year":"2003","journal-title":"Kidney Int"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.46.7.607","article-title":"Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death","volume":"46","author":"Varis","year":"1993","journal-title":"J Clin Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.36.3.276","article-title":"Occurrence of mesangial IgA and IgM deposits in a control necropsy population","volume":"36","author":"Sinniah","year":"1983","journal-title":"J Clin Pathol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12882-017-0722-3","article-title":"Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy","volume":"18","author":"Zhao","year":"2017","journal-title":"BMC Nephrol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102593","article-title":"Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy","volume":"118","author":"Moldoveanu","year":"2021","journal-title":"J Autoimmun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2018111156","article-title":"Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1","volume":"30","author":"Rizk","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/jci5535","article-title":"Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies","volume":"104","author":"Tomana","year":"1999","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/jci38468","article-title":"Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity","volume":"119","author":"Suzuki","year":"2009","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm8783","article-title":"Identification and characterization of circulating immune complexes in IgA nephropathy","volume":"8","author":"Matsumoto","year":"2022","journal-title":"Sci Adv"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2004030219","article-title":"Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human Igan1 on chromosome 6q22-23","volume":"16","author":"Suzuki","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2011121160","article-title":"Development of a model of early-onset IgA nephropathy","volume":"23","author":"Okazaki","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2019100987","article-title":"Crucial role of AIM\/CD5l in the development of glomerular inflammation in IgA nephropathy","volume":"31","author":"Takahata","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.4.417","article-title":"Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy","volume":"194","author":"Moura","year":"2001","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40620-015-0246-5","article-title":"Role of IgA receptors in the pathogenesis of IgA nephropathy","volume":"29","author":"Lechner","year":"2016","journal-title":"J Nephrol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.immunol.21.120601.141011","article-title":"IgA fc receptors","volume":"21","author":"Monteiro","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"B56","article-title":"IgA- and secretory IgA-opsonized s. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes","volume":"61","author":"Gorter","year":"1987","journal-title":"Immunology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.9.5472","article-title":"Immature neutrophils mediate tumor cell killing via IgA but not IgG fc receptors","volume":"174","author":"Otten","year":"2005","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300261","article-title":"IgA enhances netosis and release of neutrophil extracellular traps by polymorphonuclear cells via fc\u03b1 receptor I","volume":"192","author":"Aleyd","year":"2014","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.191.11.1999","article-title":"Fcalpha receptor (CD89) mediates the development of immunoglobulin a (IgA) nephropathy (Berger's disease). evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice","volume":"191","author":"Launay","year":"2000","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.09.023","article-title":"Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy","volume":"101","author":"Cambier","year":"2022","journal-title":"Kidney Int"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000115401.07980.0c","article-title":"Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy","volume":"15","author":"Moura","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2004111006","article-title":"Engagement of transferrin receptor by polymeric IgA1: Evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy","volume":"16","author":"Moura","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1159\/000098646","article-title":"Involvement of transglutaminase-2 in pathological changes in renal disease","volume":"105","author":"Ikee","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2014101000","article-title":"Current understanding of the role of complement in IgA nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2021.06.009","article-title":"Glomerular C4d deposition and kidney disease progression in IgA nephropathy: A systematic review and meta-analysis","volume":"3","author":"Jiang","year":"2021","journal-title":"Kidney Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-021-02034-7","article-title":"Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy","volume":"25","author":"Wu","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2215\/cjn.09710913","article-title":"Association of C4d deposition with clinical outcomes in IgA nephropathy","volume":"9","author":"Espinosa","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830170304","article-title":"Activation of the alternative pathway of complement by human serum IgA","volume":"17","author":"Hiemstra","year":"1987","journal-title":"Eur J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9970-6","article-title":"C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy","volume":"34","author":"Liu","year":"2014","journal-title":"J Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/cei.12961","article-title":"Targeting C3a\/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin a nephropathy in mice","volume":"189","author":"Zhang","year":"2017","journal-title":"Clin Exp Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1165394\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T04:52:36Z","timestamp":1681188756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1165394\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2023.1165394"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1165394","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"article-number":"1165394"}}